POST TEST

Question Title

1. According to the Centers for Disease Control and Prevention 2019 list of priority pathogens, which of the following Gram-negative pathogens is not included as an urgent or serious threat? (Required.)

Question Title

2. Ceftolozane-tazobactam exhibits the greatest in vitro activity against which of the following pathogens? (Required.)

Question Title

3. Which of the following newer antimicrobials exhibits the greatest in vitro activity against Acinetobacter baumannii? (Required.)

Question Title

4. Ceftazidime-avibactam exhibits in vitro activity against Enterobacterales that produce all of the following beta-lactamases except: (Required.)

Question Title

5. For a patient without impaired or augmented renal function, which of the following antimicrobial agents requires intravenous dosing every 6 hours? (Required.)

T